Clinical features of isolated proximal-type immunoglobulin G4-related sclerosing cholangitis.


Journal

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 11 05 2018
accepted: 14 12 2018
pubmed: 21 12 2018
medline: 11 1 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) presents as isolated proximal-type sclerosing cholangitis (i-SC). The present study sought to clarify the imaging differences between i-SC and Klatskin tumor. Differences between i-SC and IgG4-SC associated with autoimmune pancreatitis (AIP-SC) were also studied. Differentiating factors between i-SC and Klatskin tumor were studied. Serum IgG4 level, CA19-9 level, computed tomography (CT) findings, cholangiography findings (symmetrical smooth long stricture extending into the upper bile duct [SSLS]), endosonographic features (continuous symmetrical mucosal lesion to the hilar part [CSML]), endoscopic biopsy results, treatment, relapse, and survival were also compared between patients with i-SC and those with AIP-SC. For a differential diagnosis between i-SC (N = 9) and Klatskin tumor (N = 47), the cut-off value of serum IgG4 level was 150 mg/dL (sensitivity, 0.857, specificity, 0.966). Logistic regression analysis indicated that serum IgG4 level, presence of SSLS, presence of CSML, and presence of swollen ampulla are independent factor for identifying i-SC. Relapse rate was significantly higher in the IgG4-SC with AIP group than in the i-SC group (log rank, P = 0.046). Isolated proximal-type sclerosing cholangitis presents as a nodular lesion with SSLS and/or CSML mimicking a Klatskin tumor. Those endoscopic features might provide a diagnostic clue for i-SC. i-SC is likely to have a more favorable prognosis than IgG4-SC with AIP.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) presents as isolated proximal-type sclerosing cholangitis (i-SC). The present study sought to clarify the imaging differences between i-SC and Klatskin tumor. Differences between i-SC and IgG4-SC associated with autoimmune pancreatitis (AIP-SC) were also studied.
METHODS METHODS
Differentiating factors between i-SC and Klatskin tumor were studied. Serum IgG4 level, CA19-9 level, computed tomography (CT) findings, cholangiography findings (symmetrical smooth long stricture extending into the upper bile duct [SSLS]), endosonographic features (continuous symmetrical mucosal lesion to the hilar part [CSML]), endoscopic biopsy results, treatment, relapse, and survival were also compared between patients with i-SC and those with AIP-SC.
RESULTS RESULTS
For a differential diagnosis between i-SC (N = 9) and Klatskin tumor (N = 47), the cut-off value of serum IgG4 level was 150 mg/dL (sensitivity, 0.857, specificity, 0.966). Logistic regression analysis indicated that serum IgG4 level, presence of SSLS, presence of CSML, and presence of swollen ampulla are independent factor for identifying i-SC. Relapse rate was significantly higher in the IgG4-SC with AIP group than in the i-SC group (log rank, P = 0.046).
CONCLUSION CONCLUSIONS
Isolated proximal-type sclerosing cholangitis presents as a nodular lesion with SSLS and/or CSML mimicking a Klatskin tumor. Those endoscopic features might provide a diagnostic clue for i-SC. i-SC is likely to have a more favorable prognosis than IgG4-SC with AIP.

Identifiants

pubmed: 30570170
doi: 10.1111/den.13320
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

422-430

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2018 Japan Gastroenterological Endoscopy Society.

Auteurs

Yuri Takagi (Y)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Kensuke Kubota (K)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Takuya Takayanagi (T)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Yusuke Kurita (Y)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Ken Ishii (K)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Sho Hasegawa (S)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Akito Iwasaki (A)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Takamitsu Sato (T)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Yuji Fujita (Y)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Shingo Kato (S)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Koichi Kagawa (K)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Seitaro Watanabe (S)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Yusuke Sekino (Y)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Kunihiro Hosono (K)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Nobuyuki Matsuhashi (N)

Department of Gastroenterology, NTT Kanto Medical Center, Tokyo, Japan.

Shoji Yamanaka (S)

Department of Pathology, Yokohama City University Hospital, Kanagawa, Japan.

Toshiyasu Iwao (T)

Department of Gastroenterology, Aizu Central Hospital, Fukushima, Japan.

Koji Yoshida (K)

Department of Gastroenterology, Kawasaki Medical University, Okayama, Japan.

Atsushi Nakajima (A)

Department of Gastroenterology and Hepatology, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH